Cargando…
A photoactivable multi-inhibitor nanoliposome for tumour control and simultaneous inhibition of treatment escape pathways
Nanoscale drug delivery vehicles can facilitate multimodal therapies of cancer by promoting tumour-selective drug release. However, few are effective because cancer cells develop ways to resist and evade treatment. Here, we introduce a photoactivatable multi-inhibitor nanoliposome (PMIL) that impart...
Autores principales: | Spring, Bryan Q., Sears, R. Bryan, Zheng, Lei Zak, Mai, Zhiming, Watanabe, Reika, Sherwood, Margaret E., Schoenfeld, David A., Pogue, Brian W., Pereira, Stephen P., Villa, Elizabeth, Hasan, Tayyaba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821671/ https://www.ncbi.nlm.nih.gov/pubmed/26780659 http://dx.doi.org/10.1038/nnano.2015.311 |
Ejemplares similares
-
A nanoliposome-based photoactivable drug delivery system for enhanced cancer therapy and overcoming treatment resistance
por: Shi, Jinjin, et al.
Publicado: (2017) -
The Role of Photoactivated and Non-Photoactivated Verteporfin on Tumor
por: Wei, Changran, et al.
Publicado: (2020) -
Breaking the selectivity-uptake trade-off of photoimmunoconjugates with nanoliposomal irinotecan for synergistic multi-tier cancer targeting
por: Liang, Barry J., et al.
Publicado: (2020) -
Simultaneous quantification of actin monomer and filament dynamics with modeling-assisted analysis of photoactivation
por: Kapustina, Maryna, et al.
Publicado: (2016) -
Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions
por: Felfoul, Ouajdi, et al.
Publicado: (2016)